Osteoporosis drug Evista approved to cut risk of breast cancer
[Xinhua - Health
] - 14. Settembre 2007 - 23:40The U.S. Food and Drug Administration approved Evista Friday for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.




Crea il tuo Personal Feed
Bitzeli iGoogle Gadget
Bitzeli per Google Desktop